eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
Research ArticleStem Cells
Kynurenine signaling through the aryl hydrocarbon receptor maintains the undifferentiated state of human embryonic stem cells
- Takako Yamamoto1,
- Kunitada Hatabayashi2,
- Mao Arita1,
- Nobuyuki Yajima1,
- Chiemi Takenaka1,
- Takashi Suzuki3,
- Masatoshi Takahashi3,
- Yasuhiro Oshima2,
- Keisuke Hara2,
- Kenichi Kagawa2, and
- Shin Kawamata1,4,*
- 1Research & Development Center for Cell Therapy, Foundation for Biomedical Research and Innovation, 2-2 Minatojima Minami-machi, Chuo-ku, Kobe 650-0047, Japan.
- 2Innovative Technology Planning Department, Tokyo Electron Limited, Akasaka Biz Tower, 5-3-1 Akasaka, Minato-Ku, Tokyo 107-6325, Japan.
- 3Analytical and Measuring Instruments Division, Shimadzu Corporation, 1 Nishinokyo, Kuwahara-cho, Nagagyo-ku, Kyoto 604-8511, Japan.
- 4Riken Center for Developmental Biology, 2-1 Minatojima Minami-machi, Chuo-ku, Kobe 650-0047, Japan.
- ↵*Corresponding author. Email: kawamata{at}fbri.org
See allHide authors and affiliations
Science Signaling 25 Jun 2019:
Vol. 12, Issue 587, eaaw3306
DOI: 10.1126/scisignal.aaw3306
Vol. 12, Issue 587, eaaw3306
DOI: 10.1126/scisignal.aaw3306
Takako Yamamoto
Research & Development Center for Cell Therapy, Foundation for Biomedical Research and Innovation, 2-2 Minatojima Minami-machi, Chuo-ku, Kobe 650-0047, Japan.
Kunitada Hatabayashi
Innovative Technology Planning Department, Tokyo Electron Limited, Akasaka Biz Tower, 5-3-1 Akasaka, Minato-Ku, Tokyo 107-6325, Japan.
Mao Arita
Research & Development Center for Cell Therapy, Foundation for Biomedical Research and Innovation, 2-2 Minatojima Minami-machi, Chuo-ku, Kobe 650-0047, Japan.
Nobuyuki Yajima
Research & Development Center for Cell Therapy, Foundation for Biomedical Research and Innovation, 2-2 Minatojima Minami-machi, Chuo-ku, Kobe 650-0047, Japan.
Chiemi Takenaka
Research & Development Center for Cell Therapy, Foundation for Biomedical Research and Innovation, 2-2 Minatojima Minami-machi, Chuo-ku, Kobe 650-0047, Japan.
Takashi Suzuki
Analytical and Measuring Instruments Division, Shimadzu Corporation, 1 Nishinokyo, Kuwahara-cho, Nagagyo-ku, Kyoto 604-8511, Japan.
Masatoshi Takahashi
Analytical and Measuring Instruments Division, Shimadzu Corporation, 1 Nishinokyo, Kuwahara-cho, Nagagyo-ku, Kyoto 604-8511, Japan.
Yasuhiro Oshima
Innovative Technology Planning Department, Tokyo Electron Limited, Akasaka Biz Tower, 5-3-1 Akasaka, Minato-Ku, Tokyo 107-6325, Japan.
Keisuke Hara
Innovative Technology Planning Department, Tokyo Electron Limited, Akasaka Biz Tower, 5-3-1 Akasaka, Minato-Ku, Tokyo 107-6325, Japan.
Kenichi Kagawa
Innovative Technology Planning Department, Tokyo Electron Limited, Akasaka Biz Tower, 5-3-1 Akasaka, Minato-Ku, Tokyo 107-6325, Japan.
Shin Kawamata
Research & Development Center for Cell Therapy, Foundation for Biomedical Research and Innovation, 2-2 Minatojima Minami-machi, Chuo-ku, Kobe 650-0047, Japan.Riken Center for Developmental Biology, 2-1 Minatojima Minami-machi, Chuo-ku, Kobe 650-0047, Japan.
Submit a Response to This Article
No eLetters have been published for this article.